Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
7.82
-0.17 (-2.13%)
At close: Mar 9, 2026, 4:00 PM EDT
7.97
+0.15 (1.92%)
After-hours: Mar 9, 2026, 7:20 PM EDT
Eupraxia Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 472 | 112 | 111 | 58 | 28 | - | |
| Market Cap Growth | 271.79% | 0.65% | 90.50% | 111.19% | - | - | |
| Enterprise Value | 412 | 102 | 96 | 43 | 8 | - | |
| Last Close Price | 7.82 | 3.17 | 4.16 | 2.69 | 2.30 | - | |
| PB Ratio | 5.34 | 3.51 | 124.32 | 8.08 | 1.83 | - | |
| P/TBV Ratio | 8.09 | 65.70 | 50.06 | 7.48 | 1.75 | - | |
| Debt / Equity Ratio | 0.00 | 0.00 | 11.71 | 1.25 | 0.52 | -0.59 | |
| Net Debt / Equity Ratio | -1.00 | -1.04 | -9.96 | -1.29 | -1.04 | -0.58 | |
| Net Debt / EBITDA Ratio | 3.00 | 1.23 | 0.32 | 0.53 | 1.12 | -5.73 | |
| Net Debt / FCF Ratio | 3.52 | 1.10 | 0.43 | 0.63 | 1.31 | -31.25 | |
| Quick Ratio | 23.38 | 10.74 | 1.01 | 6.00 | 13.38 | 0.03 | |
| Current Ratio | 23.98 | 11.10 | 1.02 | 6.08 | 13.49 | 0.05 | |
| Return on Equity (ROE) | -61.02% | -157.31% | -715.19% | -178.04% | - | - | |
| Return on Assets (ROA) | -36.21% | -61.14% | -88.37% | -52.20% | -68.51% | -59.25% | |
| Return on Capital Employed (ROCE) | -33.60% | -84.80% | -3120.70% | -109.70% | -61.90% | 10.70% | |
| Earnings Yield | -6.72% | -22.84% | -25.44% | -31.75% | -68.66% | - | |
| FCF Yield | -5.35% | -26.96% | -18.77% | -25.12% | -43.73% | - | |
| Buyback Yield / Dilution | -13.17% | -40.52% | -25.21% | -55.45% | -102.75% | -0.01% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.